Atrás
Rango del Día
$1.11
$1.16
Rango de 52 Semanas
$1.10
$1.83
Volumen
4,402,822
Promedio 50D / 200D
$1.24
/
$1.34
Cierre Anterior
$1.12
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -3.9 | 0.4 |
| P/B | 0.7 | 2.9 |
| ROE % | -17.1 | 3.7 |
| Net Margin % | -37.2 | 3.9 |
| Rev Growth 5Y % | -23.5 | 10.0 |
| D/E | 0.3 | 0.2 |
Precio Objetivo de Analistas
Hold
$1.60
+39.1%
EPS Futuro
-$0.28
Ingresos Est.
550 M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
-$0.04
-$0.04 – -$0.04
|
690 M | 1 |
| FY2029 |
-$0.08
-$0.08 – -$0.08
|
650 M | 1 |
| FY2028 |
-$0.08
-$0.16 – $0.00
|
610 M | 3 |
Puntos Clave
Revenue declined -23.53% annually over 5 years
Debt/Equity of 0.34 — conservative balance sheet
Negative free cash flow of -190.82M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 8.63%
Capital efficient — spends only 2.02% of revenue on capex
Crecimiento
Revenue Growth (5Y)
-23.53%
Revenue (1Y)-14.90%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-17.14%
ROIC-9.65%
Net Margin-37.20%
Op. Margin-36.08%
Seguridad
Debt / Equity
0.34
Current Ratio3.97
Interest Coverage-2.16
Valoración
P/E Ratio
-3.91
P/B Ratio0.70
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -14.90% | Revenue Growth (3Y) | -16.17% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -23.53% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 606.88M | Net Income (TTM) | -225.73M |
| ROE | -17.14% | ROA | -11.68% |
| Gross Margin | 21.10% | Operating Margin | -36.08% |
| Net Margin | -37.20% | Free Cash Flow (TTM) | -190.82M |
| ROIC | -9.65% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.34 | Current Ratio | 3.97 |
| Interest Coverage | -2.16 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -3.91 | P/B Ratio | 0.70 |
| P/S Ratio | 1.45 | PEG Ratio | -0.02 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 882.86M | Enterprise Value | 947.38M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 606.88M | 713.14M | 863.50M | 1.00B | 1.77B |
| Net Income | -225.73M | -53.22M | -188.86M | -328.41M | -30.14M |
| EPS (Diluted) | -0.30 | -0.08 | -0.25 | -0.46 | -0.05 |
| Gross Profit | 128.05M | 311.03M | 318.13M | 288.22M | 581.52M |
| Operating Income | -218.99M | -152.07M | -157.02M | -226.25M | 18.75M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.93B | 2.20B | 2.01B | 2.17B | 2.40B |
| Total Liabilities | 663.99M | 834.76M | 622.48M | 605.61M | 714.59M |
| Shareholders' Equity | 1.27B | 1.37B | 1.39B | 1.56B | 1.69B |
| Total Debt | 433.60M | 504.44M | 326.56M | 305.55M | 254.76M |
| Cash & Equivalents | 369.07M | 431.94M | 95.88M | 153.19M | 134.71M |
| Current Assets | 581.88M | 662.09M | 309.48M | 394.53M | 823.01M |
| Current Liabilities | 146.68M | 193.10M | 200.05M | 213.48M | 330.01M |